Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)
US6080720A · kind A · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 1995 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Jul 21, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a composition for metabolic bone diseaese and/or bone fractures which comprises a pharmaceutically acceptable carrier and human neurotrophin-3 (NT-3). This invention also relates to a method for the treatment and/or prevention of metabolic bone diseaese or bone fractures which comprises administering to a patient in need of said treatment and/or prevention a medicament containing an effective amount of human neurotrophin-3 (NT-3).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.